Sam Rubin is used to working quick. Now he’s working quicker. The developer has four projects that qualify for 421a, New York’s former tax exemption program. But a deadline is looming: June 15, 2026.

When Gov. Kathy Hochul resuscitated a near-death development market two weeks ago, brokers’ phones started ringing. And they haven’t stopped. “I’ve got back-to-back calls today with developers,” Dan ...

The tax exemption known as 421a expired in 2022. A fight over its replacement, called 485x, could have major implications for the city’s future. By Mihir Zaveri Nearly every debate about New York’s ...

All the cheers as the $2 billion Innovation QNS proposal clears hurdles in the City Council will fade if the plan falters because state lawmakers refuse to replace the expired 421a tax-exemption, ...

The owners of three buildings in Manhattan, Brooklyn and Queens are accused in the suits of falsely registering initial rents with the state Division of Homes and Community Renewal (HCR) in order to ...

A tax incentive for residential development that state lawmakers are letting expire this week has been dubbed a huge developer giveaway by progressives and affordable housing advocates, costing ...

“We propose a new hybrid financing model that would combine a land value tax (LVT) and community land trusts (CLTs) to address New York’s changing fiscal environment as well as the housing needs of ...

For those who want to see New York City revive and thrive, the impending demise of the 421a housing-construction abatement, known by its section of state law, may seem like a blow. The annual $1.8 ...

The past two mayoral administrations have both highlighted the importance of housing affordability, yet little has actually been done to create affordable housing. One of the few initiatives that has ...

QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) QR-421a observed to be well ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA ...

Please provide your email address to receive an email when new articles are posted on . ProQR has dosed the first patient in a phase 1/2 trial of QR-421a for Usher syndrome type 2 or non-syndromic ...